Improving Door-to-Needle Times in Acute Ischemic Stroke
نویسندگان
چکیده
منابع مشابه
Improving Door-to-Needle Times for Acute Ischemic Stroke
Faster treatment with intravenous alteplase (tissue-type plasminogen activator) results in better outcomes. Although the benchmark door-to-needle time (DTN) has been set at 60 minutes, many centers have been able to exceed this benchmark with median times from 20 to 51 minutes. These local efforts have been supported by national and international efforts to reduce DTN time. For example, the Ame...
متن کاملSymptom-to-needle Times in Acute Ischemic Stroke and Its Prehospital Related Factors
Background: Intravenous (IV) recombinant tissue Plasminogen Activator (rtPA) (IV-rtPA) is the only FDA-approved pharmacological therapy for treatment in acute ischemic stroke and the administration of IV-rtPA is crucially time-dependent. Objectives: This study aimed to evaluate symptom-to-needle time and factors associated with the prehospital delay in patients with acute ischemic stroke refer...
متن کاملShort Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors
BACKGROUND The clinical benefit of intravenous thrombolysis (IVT) in acute ischemic stroke is time dependent. Several studies report a short median door-to-needle time (DNT; 20 min), mainly in large tertiary referral hospitals equipped with a level 1 emergency department, a dedicated stroke team available 24/7, and on-site neuroimaging facilities. Meanwhile, in daily practice, the majority of s...
متن کاملDoor-to-needle times in acute ischemic stroke: how low can we go?
Neurology® 2012;79:1 IV human recombinant tissue plasminogen activator (rt-PA) is the best proven and most effective treatment for acute ischemic stroke. The benefits of rt-PA are highly dependent on the time elapsed since stroke symptoms.1 Accordingly, the Brain Attack Coalition recommends that the time from emergency room arrival to initiation of rt-PA (that is, the “door-toneedle” time) shou...
متن کاملSimple text-messaging intervention is associated with improved door-to-needle times for acute ischemic stroke.
BACKGROUND AND PURPOSE Timely administration of intravenous tissue-type plasminogen activator (IV tPA) is associated with improved outcomes for acute ischemic stroke; yet, developing processes to consistently provide prompt treatment remains a challenge. We developed and evaluated a simple quality improvement intervention designed to improve door-to-needle (DTN) times for resident-led Code Stro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2011
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.111.621342